-The Hindu     There is little demonstrated evidence of health benefits from access to ‘improved' stoves and clean fuels Around three billion of the world's poorest people have to burn firewood, animal dung, crop waste and coal to cook food and heat homes, using traditional stoves and open fires. The health-damaging smoke that results is estimated to cause some four million premature deaths each year, principally of women and children. Although many governments, multinational...

-The Telegraph The medical fraternity is worried over the seizure of sub-standard and fake drugs, at times lethal for patients. Police on Wednesday seized 30 boxes of suspected spurious drugs from a cart in the Gandhi Maidan area. Station House Officer of Gandhi Maidan police station Rajbindu Prasad said nobody could produce transaction bills for the consignment. The drugs seized were ofloxacin (for respiratory tract infections), oflozen (for typhoid), ossopan (calcium tablets prescribed...

-The Times of India MUMBAI: It's widely known that a month's dose of cancer drugs can cost lakhs, but what isn't common knowledge is that Tata Memorial Hospital's doctors are working on alternatives that could cost less than Rs 1,000 a month. Dubbed the metronomic treatment protocol, it comprises daily consumption of a combination of low-dose medicines that are cheap because they have been around for decades. "There is no need to...

-The Business Standard USFDA's zero tolerance policy requires our drug firms to reorient not just processes but organisational cultures to serve that market credibly The following two quotes from the United States Food and Drug Administration (FDA) news releases may help put the Ranbaxy controversy in perspective. The first sums up what it is that drives the FDA and the second is typical of the challenge the pharmaceutical industry faces. (1) "The consent...

-The Hindu   Ranbaxy's fraudulent practices may have jeopardised millions of lives in India, Africa and the U.S. Exactly two weeks ago, the pharmaceuticals industry was rocked by revelations that one of the world's largest generic drug manufacturers, Ranbaxy Laboratories, pleaded guilty to seven federal criminal charges stemming from its fraudulent production practices dating back to 2008, and agreed to pay U.S. regulators $500 million in fines. Much has since been said about Ranbaxy's...